美国实体器官移植受者中皮脂腺癌的发病率与生存分析(1987-2017)
该队列研究利用移植癌症匹配研究数据,分析1987至2017年美国实体器官移植受者中皮脂腺癌的发病率和生存情况,发现移植受者皮脂腺癌发病率较一般人群升高25倍,且移植受者皮脂腺癌患者总体生存更差。
要点
- 实体器官移植受者皮脂腺癌发病率显著升高(SIR 24.8)。
- 肺移植受者及移植后发生皮肤鳞状细胞癌者风险更高。
- 移植受者皮脂腺癌患者总体死亡风险增加(aHR 2.09)。
核心结论
- 实体器官移植受者中皮脂腺癌发病率较一般人群升高25倍,且移植受者皮脂腺癌患者总体生存更差。
主要发现
- 共诊断102例皮脂腺癌,标准化发病比为24.8(95% CI 20.2-30.1)。
- 肺移植受者SIR为47.7(95% CI 20.6-94.0),移植后发生皮肤鳞状细胞癌者SIR为104.0(95% CI 62.8-163.0)。
- 男性(IRR 2.46,95% CI 1.48-4.07,P < .001)、年龄≥65岁(较0-44岁IRR 7.85,95% CI 3.85-16.0,P < .001)、使用抗胸腺细胞球蛋白诱导(IRR 1.82,95% CI 1.16-2.86,P = .009)、移植后皮肤鳞状细胞癌(IRR 4.60,95% CI 2.67-7.94,P < .001)、移植后时间≥10年(较0-1.9年IRR 8.40,95% CI 3.94-17.90,P < .001)与皮脂腺癌风险独立相关。
- 非西班牙裔黑人较非西班牙裔白人风险降低(IRR 0.28,95% CI 0.10-0.77,P = .01)。
- 移植受者皮脂腺癌患者总体死亡风险增加(aHR 2.09,95% CI 1.45-3.01),但死于皮脂腺癌者比例低(移植受者4/92 [4.3%],非移植受者235/3585 [6.6%])。
临床怎么用
- 对实体器官移植受者,尤其是肺移植、老年、男性、使用抗胸腺细胞球蛋白诱导及移植后发生皮肤鳞状细胞癌者,应警惕皮脂腺癌风险。
- 移植受者皮脂腺癌患者总体预后更差,需加强监测和随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Risk of sebaceous carcinoma (SC), a rare skin cancer associated with Muir-Torre syndrome, is elevated among solid organ transplant recipients (SOTRs). However, population studies evaluating this association and assessing survival for posttransplant cases are lacking, and further understanding of SC epidemiology in this immunosuppressed population could provide etiologic and clinical insights. OBJECTIVE: To assess SC incidence and patient survival after solid organ transplantation. DESIGN, SETTING, AND PARTICIPANTS: This cohort study, conducted from January 1, 1987, to December 31, 2017, used data from the Transplant Cancer Match Study, which links transplant and cancer registry data for 17 states and 1 metropolitan area in the United States. Altogether, these registries account for approximately 46% of all US transplants. Data on demographic and transplant characteristics as well as induction and initial maintenance immunosuppressive therapies were obtained from the transplant registry. Standardized incidence ratios (SIRs) comparing SC incidence among SOTRs to the general population were calculated. Incidence rate ratios (IRRs) comparing SC risk between SOTR subgroups were calculated using multivariate Poisson regression. Cox regression was used to compare overall survival between SC cases in SOTRs and other individuals. MAIN OUTCOMES AND MEASURES: Sebaceous carcinoma incidence and overall patient survival after transplantation compared with the general population. RESULTS: A total of 326 282 transplant procedures were performed for 301 075 patients (No. [%] age at transplant, 126 550 [38.8%] aged 0-44 years; 82 394 [25.3%] aged 45-54 years; 82 082 [25.5%] aged 55-64 years; 35 256 [10.8%] aged ≥65 years; 201 354 male patients [61.7%]; 202 557 White patients [62.1%]). A total of 102 SCs were diagnosed in 301 075 SOTRs, corresponding to a 25-fold increased incidence (SIR, 24.8; 95% CI, 20.2-30.1). Incidence was especially elevated among lung recipients (SIR, 47.7; 95% CI, 20.6-94.0) and after a posttransplant diagnosis of cutaneous squamous cell carcinoma (SIR, 104.0; 95% CI, 62.8-163.0). Among SOTRs, factors independently associated with SC risk included male sex (IRR, 2.46; 95% CI, 1.48-4.07; P < .001), race/ethnicity (non-Hispanic Black vs non-Hispanic White, IRR, 0.28; 95% CI, 0.10-0.77; P = .01), older age (IRR, 7.85; 95% CI, 3.85-16.0; ≥65 vs 0-44 years; P < .001 for trend), use of thymoglobulin induction (IRR, 1.82; 95% CI, 1.16-2.86; P = .009), posttransplant cutaneous squamous cell carcinoma (IRR, 4.60; 95% CI, 2.67-7.94; P < .001), and longer time since transplant (IRR, 8.40; 95% CI, 3.94-17.90; ≥10 vs 0-1.9 years; P < .001 for trend). Muir-Torre syndrome-associated cancers were rare among both SOTRs and others with SC (3.3%-4.1%). Among patients with SC, prior transplantation was associated with increased overall mortality (adjusted hazard ratio, 2.09; 95% CI, 1.45-3.01), although few deaths were attributed to SC (4 of 92 SOTRs [4.3%]; 235 of 3585 non-SOTRs [6.6%]). CONCLUSIONS AND RELEVANCE: Among SOTRs, results of this large cohort study suggest that SC was associated with measures of immunosuppression, and overall survival was worse than for other patients with SC. Findings also suggest a possible role for UV radiation in carcinogenesis.
引用
- Sargen MR, Cahoon EK, Lynch CF, et al. Sebaceous Carcinoma Incidence and Survival Among Solid Organ Transplant Recipients in the United States, 1987-2017. JAMA Dermatol. 2020. PMID: 33146669. doi:10.1001/jamadermatol.2020.3111
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。